首页
订购/客服:400-666-5481

RORγt inverse agonist 13

    
99.20%

源叶(MedMol)
S89375 一键复制产品信息
2170477-75-3
C23H17Cl2F3N2O4
513.29
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S89375-5mg促销
99.20%

¥1100.00 ¥880.00

4 - - - -
S89375-10mg促销
99.20%

¥1820.00 ¥1450.00

3 - - - -
S89375-25mg促销
99.20%

¥2930.00 ¥2340.00

4 - - - -
S89375-100mg促销
≥98%

¥5830.00 ¥4660.00

货期:2-3天 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: RORγt inverse agonist 13 (Compound 3i) is a potent, orally active and selective RORγt inverse agonist, with improved agent-like properties, with an IC50 of 63.8 nM
靶点: ROR-γ:63.8 nM (IC50);ROR
体外研究: RORγt inverse agonist 13 (Compound 3i) exhibits activity with an inhibition of 76% at 0.3 µM in Th17 cell differentiation assay.
体内研究: RORγt inverse agonist 13 (Compound 3i, 25 mg/kg, Orally, twice daily) demonstrats excellent in vivo PK profile in mice and good in vivo efficacy in an IMQ-induced psoriasis mice model. Animal Model: Imiquimod (IMQ)-induced psoriasis mice model. Dosage: 25 mg/kg. Administration: Orally, twice daily. Result: Brought in a significant reduction in clinical severity of psoriasis as measured through the ear erythema, back skin erythema and scaliness scales. Animal Model: Male CD-1 Mice. Dosage: 1 mg/kg (i.v.) and 5 mg/kg (p.o.)(Pharmacokinetic Analysis). Administration: IV or PO, single dose. Result: Cmax: 609.67 ng/mL (PO), 1550 ng/mL (IV).T1/2: 3.63 h (PO), 3.04 h (IV).
参考文献: 1. Nannan Sun, et al. Discovery of carboxyl-containing biaryl ureas as potent RORγt inverse agonists. Eur J Med Chem. 2020 Jul 5;202:112536.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 1.948 ml 9.741 ml 19.482 ml
5 mM 0.39 ml 1.948 ml 3.896 ml
10 mM 0.195 ml 0.974 ml 1.948 ml
50 mM 0.039 ml 0.195 ml 0.39 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×